Metabolic disease burden tied to worse outcomes in untreated chronic hepatitis B
-
May 7
Diabetes alone was linked to higher liver cancer risk and mortality in REAL-B cohort.
Browse By
Biliary Tract
Colon
Esophagus
Liver
Pancreas
Small Bowel
Stomach
The GI hospitalist: A practice-changing health care opportunity
-
April 23
-
by Vasili Kalas, MD, PhD
The model is reshaping inpatient care, despite slow national adoption.
Pancreatic cystic lesions: A case-based approach
-
April 17
-
by Ross C.D. Buerlein, MD , Himesh B. Zaver, MD , Vanessa M. Shami, MD
Dr. Vanessa Shami, along with Drs. Ross Buerlein and Himesh Zaver, review pancreatic cysts in a case-based approach.
Navigating primary sclerosing cholangitis: Diagnosis and the 5 pillars of management
-
February 1
-
by Judy A. Trieu, MD, MPH, Mahesh Krishna, MD, David N. Assis, MD
Primary sclerosing cholangitis remains a challenging disease to diagnose and manage, due to varying presentations, associated disease processes, and lack of targeted treatment.
The Latest
AI liquid biopsy flags occult metastases in ICC before surgery
-
by Julia Cipriano
EXOMIC assay may identify candidates for neoadjuvant therapy and improve preoperative risk stratification.
Late post-colonoscopy cancers tied to detection rate
-
by Julia Cipriano
Ten-year data suggest the protective effect of a high adenoma detection rate persists well beyond four years.
Metabolic disease burden tied to worse outcomes in untreated chronic hepatitis B
-
by Alun Evans
Diabetes alone was linked to higher liver cancer risk and mortality in REAL-B cohort.
Cholangitis trial supports stopping antibiotics 24 hours after drainage
-
by Noah Levine
In a 413-patient randomized trial, a single-day course matched the guideline-recommended four to seven days for clinical cure.
Nonendoscopic screening detects Barrett's esophagus in at-risk veterans without GERD
-
by Julie Greenbaum
Swallowable cell-collection device showed 100% sensitivity in veterans lacking classic reflux symptoms.
